Tuesday, November 6, 2012
Luncheon Presentation
Using Portfolio Management to Effectively Manage (and Not Manage) Innovation
Daniel Smith, MBA, Vice President, Enrich Consulting
|
» SHARED KEYNOTE SESSION
Session Chairperson
James Resch, Ph.D., Director of Strategic Intelligence, Strategy, Portfolio, and Performance, AstraZeneca Pharmaceuticals
Talk Title to be Announced
Lisa Sinclair, Ph.D., Vice President, Portfolio and Performance, AstraZeneca
Transformation of R&D Resource Management at Pfizer
William Korinek, Ph.D., Vice President, Worldwide R&D Business Operations, Pfizer, Inc.
Integrating Portfolio and Business Management
Carmel Egan, Ph.D., Vice President, Project Management, Eli Lilly & Co
A Perspective on Effective R&D Decision Making
Florian Jehle, Principal, Catenion
|
Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest to them and become an active part of the discussion at hand. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.
Topics may include:
- Understanding the impact of partnerships and co-development deals on resource and portfolio management
- Supporting agile development and agile adaptation of data into planning: How to manage uncertainty, react to outcomes efficiently, and create an agile and efficient organization
- Tying forecasting function successfully into portfolio management
- Aligning portfolio & productivity with corporate strategy to drive strategic resource allocation
- Balancing internal R&D investments and resources with external collaborations
- Right sizing: How can capacity management contribute to right sizing and outsourcing?
- Creating a governance body and corporate structure to enable agile decision making
- How can pharma translate lessons learned from other industries?
Please share your topic requests and suggestions with us: lyuan@healthtech.com
|
|
Optimizing Trial Resourcing through Operational Benchmarking & Ensuring Alignment between Study Goals and Activities - Detailed Agenda
Jeffrey Handen, Ph.D., Vice President, Clinical Solutions, Medidata Solutions
Sponsor companies are increasingly struggling with having to balance more choices and activities against even less resources than before, as R&D budgets as a whole have started to decrease across the industry. More often than not portfolio decisions are made on the basis of scientific and commercial impact with little to no consideration of resourcing and operational. The audience will gain an understanding and insights into best practices from case studies and benchmark data on how sponsors are using better resource estimating of complete trial activities to manage budget, headcount, and outsourcing considerations, and to identify and minimize non value-added work, in order to free up resources for further value-added work in support of scientific and commercial goals.
*Separate registration is required.
|
Wednesday, November 7, 2012
Session Chairperson
Florian Jehle, Principal, Catenion GmbH
» OPENING KEYNOTE PRESENTATION
Portfolio Management: Strengthening Decision Making
in R&D
Pasquale Cetera, Ph.D., Vice President, Portfolio Management & Strategy, Merck and Co.
|
The Impact of Strategic Portfolio Management on BMS BioPharma Growth
Chinweze Ahaghotu, M.S., MBA, Associate Director, Portfolio & Asset Strategy, Bristol-Myers Squibb, Co.
Seeing the Forecast for the Decision Tree: Using Collaborative Decision Making to Create Value
Kevin Connor, M.S., Executive Vice President, Decision Solutions Group, Decision Lens
Forecast Accuracy and Portfolio Decision Making
James Resch, Ph.D., Director of Strategic Intelligence, Strategy, Portfolio, and Performance, AstraZeneca Pharmaceuticals
Strategic Portfolio Management: An Abbott Discovery Perspective
Keith Glaser, Ph.D., Senior Strategic Planner and Portfolio Manager, Abbott Laboratories
Gaining Strategic View of Your Portfolio
Speaker to be announced from UMT
Session Chairperson
Shama Kajiji, Ph.D., MBA, Director, Strategy and Portfolio Integration, Johnson & Johnson
Hitting the Sweet Spot: Integrating Balanced Scorecard and Hoshin Kanri Methodologies to Develop, Deploy, and Implement Merck’s S&T Portfolio
Poppy Kroese, B.S., Enterprise Process Management Leader, Global Science, Technology, and Commercialization, Merck/Manufacturing Division
Management of a Personalized Healthcare Portfolio
Ethan Fingerman, Ph.D., Senior Manager, Pipeline and Portfolio Planning, Genentech
Portfolio Management and Partnering Strategy
Martine van Vugt, Ph.D., Vice President, Business Development and Project Management, Genmab
Case Study: Virtual Portfolio Management
Meijia Yang, Ph.D., Portfolio Management, Merck Serono Pharmaceuticals
Challenges of Portfolio Management in Small R&D Organizations
Eberhard Raemisch, M.Sc., Associate Principle Portfolio Management, Portfolio Management and Pipeline Sourcing, Nycomed GmbH
Close of Portfolio Management Executive Forum (arrive early for Strategic Resource Management Monday, November 5)
For questions or suggestions about the meeting, please contact:
Micah Lieberman
Executive Director, Conferences
BioPharma Strategy Series
Cambridge Healthtech Institute (CHI)
T: (+1) 541.482.4709
E: mlieberman@healthtech.com
|
For exhibit and partnering information, please contact:
Joseph Vacca
Business Development Manager
BioPharma Strategy Series
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5431
E: jvacca@healthtech.com
|
For media and association partnerships, please contact:
Bethany Gray
Marketing Manager
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5494
E: bgray@healthtech.com
|
